Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yafei Yu

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Hematological Oncology|October 19, 2021
Global burden and attributable risk factors of acute lymphoblastic leukemia in 204 countries and territories in 1990-2019: Estimation based on Global Burden of Disease Study 2019Yuefen Hu, Xiuping Zhang, Aijun Zhang, et al.
American Journal of Hematology|January 20, 2022
Single-dose versus low-dose rituximab in corticosteroid-resistant or relapsed ITP: A multicenter, randomized, controlled studyXiaofei Ni, Daqi Li, Chenglu Yuan, et al.
Blood Cancer Journal|March 16, 2022
Clonal hematopoiesis in primary immune thrombocytopeniaYanming Wang, Tianshu Yu, Qiaofeng Dong, et al.
British Journal of Haematology|November 26, 2021
Atorvastatin restores imbalance of cluster of differentiation 4 (CD4)<sup>+</sup> T cells in immune thrombocytopenia in vivo and in vitroPengcheng Xu, Yajing Zhao, Tianshu Yu, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 27, 2015
A novel in vitro method to model the fate of subcutaneously administered biopharmaceuticals and associated formulation componentsHanne M Kinnunen, Vikas Sharma, Luis Rodrigo Contreras-Rojas, et al.
The Lancet. Haematology|March 26, 2021
Dexamethasone plus oseltamivir versus dexamethasone in treatment-naive primary immune thrombocytopenia: a multicentre, randomised, open-label, phase 2 trialLu Sun, Juan Wang, Linlin Shao, et al.
American Journal of Hematology|September 2, 2020
High-dose dexamethasone plus recombinant human thrombopoietin vs high-dose dexamethasone alone as frontline treatment for newly diagnosed adult primary immune thrombocytopenia: A prospective, multicenter, randomized trialYafei Yu, Miaomiao Wang, Yu Hou, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Hematological Oncology|October 19, 2021
Global burden and attributable risk factors of acute lymphoblastic leukemia in 204 countries and territories in 1990-2019: Estimation based on Global Burden of Disease Study 2019Yuefen Hu, Xiuping Zhang, Aijun Zhang, et al.
American Journal of Hematology|January 20, 2022
Single-dose versus low-dose rituximab in corticosteroid-resistant or relapsed ITP: A multicenter, randomized, controlled studyXiaofei Ni, Daqi Li, Chenglu Yuan, et al.
Blood Cancer Journal|March 16, 2022
Clonal hematopoiesis in primary immune thrombocytopeniaYanming Wang, Tianshu Yu, Qiaofeng Dong, et al.
British Journal of Haematology|November 26, 2021
Atorvastatin restores imbalance of cluster of differentiation 4 (CD4)<sup>+</sup> T cells in immune thrombocytopenia in vivo and in vitroPengcheng Xu, Yajing Zhao, Tianshu Yu, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 27, 2015
A novel in vitro method to model the fate of subcutaneously administered biopharmaceuticals and associated formulation componentsHanne M Kinnunen, Vikas Sharma, Luis Rodrigo Contreras-Rojas, et al.
The Lancet. Haematology|March 26, 2021
Dexamethasone plus oseltamivir versus dexamethasone in treatment-naive primary immune thrombocytopenia: a multicentre, randomised, open-label, phase 2 trialLu Sun, Juan Wang, Linlin Shao, et al.
American Journal of Hematology|September 2, 2020
High-dose dexamethasone plus recombinant human thrombopoietin vs high-dose dexamethasone alone as frontline treatment for newly diagnosed adult primary immune thrombocytopenia: A prospective, multicenter, randomized trialYafei Yu, Miaomiao Wang, Yu Hou, et al.
Pageof 3